T-cell receptor ζ-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma

Cancer Research

Volumn 57, Issue 16, 1997, Pages 3517-3519

  Cardi, Gaetano ^a,b   Heaney, John A ^a   Schned, Alan R ^a   Phillips, Dorothy M ^a   Branda, Mark T ^a   Ernstoff, Marc S ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; T LYMPHOCYTE RECEPTOR DELTA CHAIN;

ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOBLOTTING; KIDNEY CARCINOMA; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

BIOLOGICAL MARKERS; CARCINOMA, RENAL CELL; HUMANS; IMMUNITY, CELLULAR; KIDNEY NEOPLASMS; LYMPHOCYTES; LYMPHOCYTES, TUMOR-INFILTRATING; RECEPTORS, ANTIGEN, T-CELL;

EID: 0030816213     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. + phenotype in lymphocytes that infiltrate subcutaneous metastases of human melanoma. Cancer Res, 49: 6562-6565, 1989.
2. 1ck in T cells infiltrating human renal cell carcinoma. Cancer Res., 53: 5613-5616, 1993.
3. Farace, F., Angevin, E., Vanderplancke, J., Escudier, B., and Triebel, F. The decreased expression of CD3 ζ chains in cancer patients is not reversed by IL-2 administration. Int. J. Cancer (Phila.), 59: 752-755, 1994.
4. Franck, S. J., Niklinska, B. B., Orloff, D. G., Mercep, M., Ashwell, J. D., and Klausner, R. D. Structural mutations of the T-cell receptor ζ chain and its role in T-cell activation. Science (Washington DC), 249: 174-177, 1990.
5. Liu, C. P., Ueda, R., She, J., Sancho, J., Wang, B., Weddell, G., Loring, J., Kurahara, C., Dudley, E. C., Hayday, A., Terhorst, C., and Huang, M. Abnormal T-cell development in CD3-ζ-/-mutant mice and identification of a novel T-cell population in the intestine. EMBO J., 12: 4863-4875, 1993.
6. Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J-L., Vivier, E., Anderson, P., and Kiessling, R. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T cells and NK cells of patients with colorectal carcinoma. Cancer Res., 53: 5610-5612, 1993.
7. Ochoa, A. C., and Longo, D. L. Alterations of signal transduction in T cells from cancer patients. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Important Advances in Oncology, pp. 43-54. Philadelphia: J. B. Lippincott Co., 1995.
8. Zier, K., Gansbacher, B., and Salvadori, S. Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy. Immunol. Today, 17(Suppl. 1). 39-45, 1996.
9. Noda, S., Nagata-Narumiya, T., Kosugi, A., Narumizy, S., Ra, C., Fujiwara, H., and Hamaoka, T. Do structural changes of T cell receptor complex occur in tumor-bearing state? Jpn. J. Cancer Res., 86: 383-394, 1995.
10. Franco, J. L., Ghosh, P., Wiltrout, R. H., Carter, C. R. D., Zea, A. H., Momozaki, N., Ochoa, A. C., Longo, D. L., Sayers, T. J., and Komschlies, K. L. Partial degradation of T-cell signal transduclion molecules by contaminating granulocyles during protein extraction of splenic T cells from tumor-bearing mice. Cancer Res., 55: 3840-3846, 1995.
11. Berd, D., Maguire, H. C., Jr., and Mastrangelo, M. J. Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide. Cancer Res., 46: 2572-2577, 1986.
12. Tartour, E., Latour, S., Mathiot, C., Thiounn, N., Mosseri, V., Joyeux, I., D'Enghien, C. D., Lee, R., Debre, B., and Fridman, W. H. Variable expression of CD3-ζ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int. J. Cancer, 63: 205-212, 1995.
13. Pryzwansky, K. B., Martin, L. E., and Spitznagel, J. K. Immunocytochemical localization of myeloperoxidase, lactoferrin, lysozyme and and neural proteases in human monocytes and neutrophilic granulocytes. J. Reticuloendothel. Soc., 24: 295-310, 1978.
14. Wang, Q., Stanley, J., Kudoh, S., Myles, J., Kolenko, V., Yi, T., Tubbs, R., Bukowski, R., and Finke, J. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. J. Immunol., 155: 1382-1392, 1995.
15. Levey, D. L., and Srivastava, P. K. T cells from late tumor-bearing mice express normal levels of p561ck, p59fyn, ZAP-70, and CD3 ζ despite suppressed cytolytic activity. J. Exp, Med., 182: 1029-1036, 1995.